11 September, 2017
They anticipate the AMGN stock will hit $186.58 on a short term (12 month) basis. The Bowling Portfolio Management Llc holds 55,749 shares with $8.15M value, down from 64,738 last quarter.
Mizuho reiterated their buy rating on shares of Amgen Inc. Swiss National Bank now owns 2,636,008 shares of the medical research company's stock worth $432,490,000 after buying an additional 551,600 shares during the last quarter. About 21 shares traded. Amgen Inc. (NASDAQ:AMGN) has noticeable measure of stock volatility, for this average true range is an exponential moving average (14 trading days) of the True Ranges. It has underperformed by 11.43% the S&P500.
Eagle Global Advisors Llc decreased its stake in Amgen Inc (AMGN) by 65.09% based on its latest 2016Q4 regulatory filing with the SEC. The stock decreased 0.04% or $0.07 on September 8, reaching $180.64.
About 49,662 shares traded. (NYSE:VTR) has risen 3.44% since September 8, 2016 and is uptrending. It has underperformed by 16.70% the S&P500.
Since May 24, 2017, it had 0 insider buys, and 2 insider sales for $1.02 million activity. 3,700 shares were sold by BALTIMORE DAVID, worth $569,541 on Wednesday, May 31. Patton Cynthia M sold 2,922 shares worth $451,164. Investors of record on Wednesday, February 15th will be issued a $1.15 dividend. Its down 0.10, from 1.25 in 2016Q3.
A number of other institutional investors also recently modified their holdings of AMGN.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Camelot Portfolios LLC purchased a new stake in shares of Amgen in the first quarter valued at about $1,429,000. Pdts Prns Limited Liability owns 43,069 shares. The P/S ratio for Amgen Inc.is 5.75. Jackson Grant Investment Advisers Inc. now owns 636 shares of the medical research company's stock valued at $104,000 after purchasing an additional 4 shares in the last quarter. (NASDAQ:AMGN) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). Flossbach Von Storch Ag holds 1.39 million shares. Community Financial Bank Na owns 8,500 shares. Ariel Advsr Llc has 1.27% invested in Amgen, Inc. This dividend represents a yeild of $2.60 which is the dividend as a percentage of the current share price.
Ns Advisors Llc holds 9.77% of its portfolio in DST Systems, Inc. for 64,736 shares. Connecticut-based Pettee Investors has invested 0.72% in Amgen, Inc. (NASDAQ:AMGN). State Farm Mutual Automobile Insurance accumulated 0.67% or 3.19M shares. Girard Prtn Limited holds 27,783 shares or 1.18% of its portfolio. Bridges Counsel invested 0.91% of its portfolio in Amgen, Inc. Sumitomo Mitsui Asset Ltd reported 56,228 shares. Chicago Equity Ptnrs Ltd Liability Corp reported 0.88% of its portfolio in Amgen, Inc. (NASDAQ:AMGN) or 2,404 shares.
Among 21 analysts covering Amgen Inc. One equities research analyst has rated the stock with a sell rating, eleven have issued a hold rating, twelve have issued a buy rating and two have assigned a strong buy rating to the company's stock. Therefore 48% are positive.
In addition to Deutsche Bank reporting its stock price target, a total of 17 brokers have released a report on Amgen Inc. The firm earned "Overweight" rating on Saturday, August 29 by Piper Jaffray. On July 26 the company was downgraded to "Market Perform" from "Outperform" in a report from BMO Capital. On Friday, July 28 the stock rating was maintained by Oppenheimer with "Buy". The stock has "Neutral" rating by Citigroup on Thursday, February 25. Oppenheimer maintained it with "Buy" rating and $203.0 target in Wednesday, August 16 report.
Morgan Stanley is a financial holding company. Stifel Nicolaus initiated the stock with "Buy" rating in Tuesday, August 4 report. More interesting news about Amgen, Inc. (NASDAQ:AMGN) on Wednesday, July 26 to "Market Perform" rating. Leerink Swann restated a market perform rating and issued a $161.00 price target on shares of Amgen in a research report on Thursday, June 22nd. The firm has "Hold" rating given on Monday, June 12 by Jefferies.
Among 3 analysts covering Rogers Corp (NYSE:ROG), 3 have Buy rating, 0 Sell and 0 Hold. Argus Research has "Buy" rating and $185 target.
Since May 24, 2017, it had 0 buys, and 2 selling transactions for $1.67 million activity. Therefore 77% are positive. The Blackstone Group L.P. had 50 analyst reports since August 9, 2015 according to SRatingsIntel. The stock of Ventas, Inc. JP Morgan upgraded Geopark Ltd (NYSE:GPRK) on Monday, March 13 to "Overweight" rating. The firm has "Buy" rating given on Wednesday, July 12 by Oppenheimer. The company was downgraded on Tuesday, November 15 by Sidoti. The firm has "Equal Weight" rating by Barclays Capital given on Monday, May 2.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
